On Monday, August 26, we shall commemorate Krishna Janmashtami. Hindus all throughout the world celebrate the significant Hindu event that commemorates the birth of the Hindu deity Krishna with great fervor and joy. The Reserve Bank of India (RBI) has declared some cities’ banks closed because of the event in its yearly list of bank […]
 FSN E-Commerce Ventures (Nykaa) had a spike in intraday trading on August 23 of almost 9% to reach a 52-week high, following block deals that saw 4.09 crore shares, or 1.4% of the company’s ownership, exchange hands. Pre-IPO investor Harindarpal Singh Banga was most likely the seller. According to media sources, Banga and his spouse
After block trades transfer 1.4% of the stock, Nykaa shares rise by about 8% Read More »
Markets regulator Sebi has banned industrialist Anil Ambani from the securities market for five years after concluding that he engineered a fraudulent scheme to siphon off funds from Reliance Home Finance. Ambani had declared himself bankrupt before a UK court back in February 2020. In addition, the regulator fined Ambani a whooping Rs. 25 crore
According to Axis Securities, the pharma sector recorded 11% YoY and 4% QoQ revenue growth in Q1FY25, led by the strength of the home market, the introduction of new products, cost optimization, and the expansion of US businesses. The top choices are Lupin, Aurobindo Pharma, and Krishna Institute of Medical Sciences. According to a recent
Axis Securities has selected pharma stocks such as Lupin, KIMS, and Aurobindo Pharma Read More »
It is expected that the Interarch Building Products IPO share allotment will be finalized later today. Shares will be distributed to investors through a lottery, with the registrar overseeing the entire process. Investors learn on the allotment date how many shares they have been allocated in relation to the bids placed. They can go to
Only when it receives the appropriate valuation will Hindalco Industries list Novelis, its US-based business, according to managing director Satish Pai. Our primary goal in doing this IPO was to secure a higher valuation for Novelis. After the company’s most recent quarterly reporting, Pai told investors, “I think what was clear is that we were
MD: Hindalco will only float Novelis at its preferred valuation Read More »
After the business announced the introduction of its updated Jupiter 110 two-wheeler on Thursday, shares of TVS Motor business jumped 4% on Friday to reach a new all-time high of Rs 2,818 on the BSE. Subsequently, the international brokerage house UBS increased its target price of Rs 3,200 for the shares, signifying an 18% potential
The Rs 67.36 crore Indian Phosphate IPO is a book-built offering. This is a brand-new 68.04 lakh share offering. August 26, 2024, is when the Indian Phosphate IPO subscription period commences, and it ends on August 29, 2024. On Friday, August 30, 2024, the allocation for the Indian Phosphate IPO is anticipated to be completed.
Indian Phosphate IPO Date, Price, GMP, Review Read More »
In the most recent semi-annual September rejig of NSE indices, Vodafone Idea was removed from both the Nifty 500 and the Nifty Midcap 100. Vodafone Idea shares fell 2.35 percent on Friday (August 23) to settle at Rs 15.82 apiece on the NSE. The company’s current market capitalization is Rs 1,07,655.91 crore, with a free-float
NSE rejig: Vodafone Idea To depart Nifty 500 And Nifty Midcap 100 Read More »
Jerome Powell, the chair of the Federal Reserve, made it abundantly evident on Friday that safeguarding the labor market was now the central bank’s top priority and that it would not hesitate to switch to interest rate reductions in the closing weeks of a presidential election campaign. Federal Reserve’s Battle With Inflation The Federal Reserve’s
We strongly advise against making investment decisions based solely on the target prices mentioned on this website. These target prices are merely predictions, and investing in the stock market inherently involves risk. The information provided on this site is intended for informational and educational purposes only and should not be considered financial advice or recommendations for any stock.